You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alzheimer's disease (AD)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Sarcoidosis Trial in Columbus (nicotine patch)

Completed
  • Pulmonary Sarcoidosis
  • nicotine patch
  • Columbus, Ohio
    The Ohio State University
Nov 1, 2021

Sickle Cell Disease Trial (Crizanlizumab, control)

Not yet recruiting
  • Sickle Cell Disease
  • (no location specified)
Jul 19, 2022

Opioid-use Disorder, Opioid Dependence, Opioid Abuse Trial in Minneapolis (Transcranial Direct Current Stimulation (tDCS))

Recruiting
  • Opioid-use Disorder
  • +2 more
  • Transcranial Direct Current Stimulation (tDCS)
  • Minneapolis, Minnesota
    University of Minnesota
Mar 3, 2022

Acute Coronary Syndrome, Anxiety Trial (hand massage group)

Not yet recruiting
  • Acute Coronary Syndrome
  • Anxiety
  • hand massage group
  • (no location specified)
Oct 11, 2023

NSCLC Trial

Not yet recruiting
  • Non-small Cell Lung Cancer
    • (no location specified)
    Sep 14, 2022

    Aging, Parkinson Disease Trial in Tucson, Gainesville (Medx Console System, Sham Medx Console System, Vielight 810 intranasal

    Recruiting
    • Aging
    • Parkinson Disease
    • Medx Console System
    • +3 more
    • Tucson, Arizona
    • +1 more
    Sep 15, 2022

    Pediatric IBD, Pediatric Crohns Disease, Pediatric Ulcerative Colitis Trial in Hamilton (Exercise training program)

    Completed
    • Pediatric Inflammatory Bowel Diseases
    • +2 more
    • Exercise training program
    • Hamilton, ONT, Canada
      McMaster Children's Hospital
    Oct 20, 2022

    Tumor-induced Osteomalacia Disease Monitoring Program

    Recruiting
    • Tumor-induced Osteomalacia (TIO)
    • No intervention
    • New Haven, Connecticut
    • +3 more
    Jul 29, 2022

    GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)

    Active, not recruiting
    • GVHD, Chronic
    • Hematological Malignancy
    • Lee Symptom Scala
    • Copenhagen, Denmark
      Rigshospitalet
    Jul 14, 2022

    Renal Insufficiency Trial in Miami, Orlando, Saint Paul (Epetraborole)

    Completed
    • Renal Insufficiency
    • Miami, Florida
    • +2 more
    Jul 13, 2022

    Periodontitis, Obesity Trial in Bauru (antimicrobial photodynamic therapy (aPDT), Control)

    Recruiting
    • Periodontitis
    • Obesity
    • antimicrobial photodynamic therapy (aPDT)
    • Control
    • Bauru, São Paulo, Brazil
      Bauru School of Dentistry
    Oct 9, 2023

    Nephrotic Syndrome in Children Trial in China (Adrenocorticotrophic Hormone, Steroid)

    Recruiting
    • Nephrotic Syndrome in Children
    • Wuhan, Hubei, China
    • +7 more
    Oct 8, 2023

    Crohn Disease Trial in Stony Brook (Fecal Microbial Transplantation)

    Completed
    • Crohn Disease
    • Fecal Microbial Transplantation
    • Stony Brook, New York
      Stony Brook University Hospital
    Feb 18, 2022

    Cardiovascular Disease Trial in Nashville (Tailored intervention)

    Not yet recruiting
    • Cardiovascular Disease
    • Tailored intervention
    • Nashville, Tennessee
      Tennessee Valley Healthcare System Nashville Campus, Nashville,
    Jan 18, 2022

    Atherosclerosis, Peripheral Arterial Disease Trial in Moscow (Allicor, Placebo)

    Not yet recruiting
    • Atherosclerosis
    • Peripheral Arterial Disease
    • Allicor
    • Placebo
    • Moscow, Russian Federation
      Institute for Atherosclerosis Research
    Apr 16, 2023

    Wilson Disease Trial in Paris (Ophthalmological exam)

    Completed
    • Wilson Disease
    • Ophthalmological exam
    • Paris, France
      Hôpital Fondation A. de Rothschild
    Mar 2, 2022

    Seasonal Factors and COVID 19

    Completed
    • COVID-19 Pandemic
    • Polymerase chain reaction
    • İzmir, Turkey
      IKCU, Atatürk Eğitim ve Araştırma Hastanesi, Acil Tıp
    Mar 1, 2022

    Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)

    Not yet recruiting
    • Primary Prevention of Atherosclerotic Cardiovascular Disease
    • Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
    • Placebo in 1.5ml
    • (no location specified)
    Feb 13, 2023

    Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))

    Recruiting
    • Cardiovascular Risk
    • +2 more
    • Birmingham, Alabama
    • +768 more
    Dec 23, 2022

    Outcomes of Obstetric Patients With COVID-19 Disease in the ICU

    Completed
    • COVID-19
    • +3 more
    • intensive care follow-up
    • Bursa, Yıldırım, Turkey
      Derya Karasu
    Mar 2, 2022

    Hypertension, Medication Adherence Trial in Zhengzhou (behavior management for anti-hypertensive medication, group)

    Completed
    • Hypertension
    • Medication Adherence
    • behavior management for anti-hypertensive medication
    • placebo group
    • Zhengzhou, Henan, China
      Senior Residences of Henan Province
    Jul 10, 2023

    End-stage Renal Disease Trial (Xeltis Hemodialysis Access (aXess) graft)

    Not yet recruiting
    • End-stage Renal Disease
    • Xeltis Hemodialysis Access (aXess) graft
    • (no location specified)
    Jul 21, 2022

    Salivary Gland Tumor Trial in Philadelphia (MRI)

    Recruiting
    • Salivary Gland Tumor
    • MRI
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Jun 19, 2022

    Autoimmune Diseases, Lupus Erythematosus, Systemic, Communicable Diseases Trial in Atlanta

    Enrolling by invitation
    • Autoimmune Diseases
    • +2 more
      • Atlanta, Georgia
      • +2 more
      May 17, 2022

      Molar, Third, Periodontal Pocket Trial in Alcorcón ("Distal Flap Reduction" Group, "Only Exodontia" Group)

      Recruiting
      • Molar, Third
      • Periodontal Pocket
      • "Distal Flap Reduction" Group
      • "Only Exodontia" Group
      • Alcorcón, Madrid, Spain
        Clinica Universitaria Universidad Rey Juan Carlos
      Feb 9, 2023